[finder's credit: paeyl]
Researchers at the University of Kansas are embarking on an NIH-funded project to develop a male contraceptive pill. Rather than being hormone-based, the plan is to chemically block the action of several fertility-critical enzymes. About half a million compounds will be tested in the project, wehich has a declared goal of 100% effectiveness with no risky side effects.